Drug Pipeline

Busulfan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
59
Active Studies
30
Recruiting
5
Phase 3
10
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06872333
Allo HSCT for High Risk Hemoglobinopathies
Trial arms changed: 4 -> 5
2026-05-15 NCT07566377
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Trial arms changed: 6 -> 2
2026-05-15 NCT07566377
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Trial sites reduced: 7 -> 1 locations
Active Studies by Phase
Phase 3
3
Phase 2/3
2
Phase 2
34
Phase 1/2
12
Phase 1
5
Early Phase 1
1
Not specified
2
Active Trials — top 25 of 59
NCT IDTitleConditionStatus
Phase 3
NCT03126916 Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With… Ganglioneuroblastoma Recruiting
NCT06079879 A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in… Essential Thrombocythemia Recruiting
NCT04547049 A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From… Leukemia Active, Not Recruiting
Phase 2/3
NCT04708054 Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With… Acute Myeloid Leukemia Recruiting
NCT04217278 A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS… Acute Myeloid Leukaemia Active, Not Recruiting
Phase 2
NCT06252870 Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by… Graft Versus Host Disease Recruiting
NCT03579875 Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders Fanconi Anemia Recruiting
NCT05917405 Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults… Acute Myeloid Leukemia in Remission Recruiting
NCT06207799 Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With… Multiple Myeloma Recruiting
NCT07228624 Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With… Myelodysplastic/Myeloproliferative Neoplasm Recruiting
NCT06345495 High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients… Splenomegaly Recruiting
NCT03970096 Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant… Acute Leukemia Recruiting
NCT04644016 Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant… AML Recruiting
NCT05735717 MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Hematologic Malignancy Recruiting
NCT04339777 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity Lymphoproliferative Disorders Recruiting
NCT05027945 A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS… Immunodeficiency Recruiting
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and… Acute Biphenotypic Leukemia Recruiting
NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer Acute Myelogenous Leukemia Recruiting
NCT02727803 Personalized NK Cell Therapy in CBT Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recruiting
NCT01861106 Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations GATA2 Recruiting
NCT06872333 Allo HSCT for High Risk Hemoglobinopathies Graft Failure Recruiting
NCT05564390 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… Acute Myeloid Leukemia Recruiting
NCT03674411 Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy Acute Myeloid Leukemia Active, Not Recruiting
NCT03121014 Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to… Acute Myeloid Leukemia Active, Not Recruiting
NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced… Acute Lymphoblastic Leukemia Active, Not Recruiting
Sponsors Running Busulfan Trials
Disease Areas
Get alerts when Busulfan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free